Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124067182 | 12406718 | 2 | F | 2014 | 20160817 | 20160526 | 20160824 | EXP | CA-PFIZER INC-2015146909 | PFIZER | 55.00 | YR | F | Y | 0.00000 | 20160824 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124067182 | 12406718 | 1 | SS | ENBREL | ETANERCEPT | 1 | UNK | Y | 0 | ||||||||||
| 124067182 | 12406718 | 2 | SS | ENBREL | ETANERCEPT | 1 | Y | 0 | |||||||||||
| 124067182 | 12406718 | 3 | PS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | UNK | Y | 11719 | ||||||||||
| 124067182 | 12406718 | 4 | SS | PREDNISONE. | PREDNISONE | 1 | UNK | U | 0 | ||||||||||
| 124067182 | 12406718 | 5 | SS | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | Unknown | UNK | Y | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124067182 | 12406718 | 1 | Rheumatoid arthritis |
| 124067182 | 12406718 | 2 | Rheumatoid arthritis |
| 124067182 | 12406718 | 3 | Rheumatoid arthritis |
| 124067182 | 12406718 | 5 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124067182 | 12406718 | OT |
| 124067182 | 12406718 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124067182 | 12406718 | Angiopathy | |
| 124067182 | 12406718 | Back pain | |
| 124067182 | 12406718 | Cough | |
| 124067182 | 12406718 | Drug ineffective | |
| 124067182 | 12406718 | Fatigue | |
| 124067182 | 12406718 | Hypersensitivity | |
| 124067182 | 12406718 | Injection site reaction | |
| 124067182 | 12406718 | Lung disorder | |
| 124067182 | 12406718 | Muscle disorder | |
| 124067182 | 12406718 | Musculoskeletal disorder | |
| 124067182 | 12406718 | Pharyngitis streptococcal | |
| 124067182 | 12406718 | Psychomotor hyperactivity | |
| 124067182 | 12406718 | Skin discolouration | |
| 124067182 | 12406718 | Skin disorder | |
| 124067182 | 12406718 | Viral pharyngitis | |
| 124067182 | 12406718 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124067182 | 12406718 | 1 | 2014 | 2014 | 0 | |
| 124067182 | 12406718 | 3 | 2014 | 0 |